Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rallybio (RLYB) Equity Average (2023 - 2025)

Rallybio's Equity Average history spans 3 years, with the latest figure at $54.5 million for Q3 2025.

  • For Q3 2025, Equity Average fell 27.74% year-over-year to $54.5 million; the TTM value through Sep 2025 reached $54.5 million, down 27.74%, while the annual FY2024 figure was $83.9 million, N/A changed from the prior year.
  • Equity Average for Q3 2025 was $54.5 million at Rallybio, up from $50.0 million in the prior quarter.
  • Across five years, Equity Average topped out at $147.2 million in Q2 2023 and bottomed at $50.0 million in Q2 2025.
  • The 3-year median for Equity Average is $80.0 million (2024), against an average of $88.0 million.
  • The largest annual shift saw Equity Average plummeted 42.61% in 2024 before it dropped 27.74% in 2025.
  • A 3-year view of Equity Average shows it stood at $114.9 million in 2023, then tumbled by 42.34% to $66.2 million in 2024, then dropped by 17.72% to $54.5 million in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Equity Average are $54.5 million (Q3 2025), $50.0 million (Q2 2025), and $57.9 million (Q1 2025).